Famotidine Powder, For Suspension
Product Images NDC 72603-171

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 72603-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 mL (Famotidine Oral Suspension 40mg Per 5ml)

50 mL (Famotidine Oral Suspension 40mg Per 5ml)
Famotidine for Oral Suspension, USP 40 mg/5 mL powder for suspension in a 50 mL bottle, labeled for oral use only. The product contains 400 mg famotidine per 5 mL reconstituted suspension. Manufactured by NorthStar Rx LLC, with directions for reconstitution and storage instructions also shown on the label.*
FDA Label Image

Structure (Famotidine Structure)

Structure (Famotidine Structure)
Chemical structure of famotidine, a molecule featuring sulfur, nitrogen, oxygen atoms arranged in various rings and chains, consistent with the active ingredient famotidine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.